What “Turnaround Time” Actually Measures
When a manufacturer advertises a “5–7 day turnaround,” that figure almost always describes one segment of a much longer pipeline: the time the lab spends producing trays after a case is approved. The number your practice actually feels is different — the elapsed time from submitting a scan to placing the first aligner in a patient’s mouth. Those two clocks can differ by weeks.
Turnaround is a chain, not a step. It runs through case submission, treatment-plan design, your approval, manufacturing, quality control and shipping. A partner can be genuinely fast in the lab and still be slow to the chair if any other link is loose. So the useful question is never simply “how fast are you?” but “fast at which part, and measured from where to where?”
The Real Stages Between Submission and Delivery
Break a single case into its stages and it becomes clear where days accumulate. Each stage has an owner and a realistic duration, and the sum — not any single stage — is what your patient experiences.
Swipe to compare all columns →
| Stage | Who Owns It | What Drives the Time |
|---|---|---|
| Case submission & intake | Practice | Scan quality, prescription completeness, correct case identification |
| Treatment-plan design (3D setup) | Manufacturer | Case complexity, planner capacity, staging decisions |
| Setup review & approval | Practice (clinician) | How quickly the doctor reviews, and how many revision rounds are needed |
| Manufacturing (print, thermoform, finish) | Manufacturer | Batch scheduling, number of trays, material handling |
| Quality control & packaging | Manufacturer | Inspection protocol, remake rate, serialization |
| Shipping & customs | Carrier / manufacturer | Origin, destination, service level, customs clearance |
Two of these stages sit with the practice rather than the lab: submission and approval. In many programs they are the single largest source of avoidable delay — which is good news, because they are the parts you can improve without changing suppliers. Getting STL records right the first time and reviewing setups promptly often shortens total turnaround more than any lab speed-up.
Quoted Production Time vs. True Door-to-Door Time
The production time a manufacturer quotes is a real number, but it is not the number to plan a patient around. It typically starts at approval and ends at dispatch. Everything before approval — design plus your review — and everything after dispatch — transit and customs — is excluded from that figure.
When you compare two suppliers, compare the same clock. Ask each for design turnaround, production turnaround, and typical transit to your location, then add your own realistic approval time. The sum is what “fast” means for your practice. A supplier quoting three days of production can easily deliver later than one quoting six, once design queues and shipping lanes are included.
- Design turnaround — submission to a setup ready for your review.
- Production turnaround — your approval to dispatch from the lab.
- Transit & clearance — dispatch to your door, including customs.
A fourth timing is worth asking about explicitly: revision turnaround — how quickly a requested change to the setup comes back. On complex cases it can matter more than any of the three above.
Where Turnaround Actually Slips
Most delays are not caused by slow printing. They hide in the handoffs between stages, where a case waits on information or a decision.
Incomplete or low-quality submissions
A setup cannot begin until the records are usable. Missing arches, an unreliable bite, or an unclear prescription bounces the case back before the design clock even starts. Clean records up front are the cheapest speed you can buy — our STL file requirements and a complete prescription in the doctor portal remove most of this friction.
Slow or piecemeal approvals
The setup review is the stage practices most consistently underestimate. A plan can sit in an inbox for days, and each round of vague feedback triggers a full design cycle. Reviewing promptly and giving specific, consolidated feedback is often the single biggest lever on total turnaround. Our guide on how to read and approve a 3D setup is built to make that first review decisive.
Revision loops
Every revision is a miniature treatment-planning cycle. Two or three rounds can quietly double design time. Fewer, clearer revisions — enabled by sound planning and realistic expectations — keep a case moving; our notes on reducing refinements apply directly here.
Shipping and customs
For international shipments, customs clearance is the least predictable link in the chain. Regulatory documentation, tariff coding and destination requirements can hold a package that left the lab exactly on time. A manufacturer with the right registrations for your market tends to clear customs with less friction.
Fast Isn’t Free: The Speed–Quality Trade-off
The fastest possible production is easy to promise and expensive to live with. If speed comes from compressing planning or thinning quality control, the cost reappears later as refinements, remakes and mid-course corrections — each one a fresh turnaround cycle for the same patient. A rushed case is not actually finished; it is deferred.
True turnaround is measured per completed result, not per shipment. A partner that delivers a well-planned, well-inspected case in a few extra days will beat a faster one that generates a refinement round eight weeks into treatment. This is a large part of why certified outsourced production often outperforms a rushed in-house setup on real, end-to-end time — and why manufacturing quality control belongs in any honest turnaround conversation.
Shipping, Customs and Multi-Market Logistics
For practices and DSOs operating across regions, logistics is where turnaround becomes a supply-chain question. Origin location, carrier options, service levels and customs each shape door-to-door time — and they vary by destination market. A production number quoted at the factory gate says little about what arrives in the UK, the US, Australia or the EU.
A manufacturer serving several markets should be able to give you typical transit and clearance times to your country, not just an origin-side figure. Established registrations in your market — FDA, CE / EU MDR, MHRA, TGA — reduce clearance friction as well as clinical and legal risk. If you run multiple locations, ask how cases are batched and routed so that one site’s delay doesn’t stall the rest.
How to Evaluate a Manufacturer on Turnaround
Turn the headline into a set of answerable questions. A partner confident in their operation will give you specific numbers rather than adjectives.
- Define the clockAsk exactly what the quoted turnaround includes and excludes, and get the start and stop points in writing.
- Get all three timingsDesign (submission to setup), production (approval to dispatch), and typical transit to your location.
- Ask about revisionsHow quickly does a requested setup change come back, and how are revision rounds counted?
- Check visibilityCan you see live case status in a portal, or do you chase updates by email? Real-time tracking removes guesswork.
- Look at consistency, not best caseAsk for typical and worst-case timings, and the remake or refinement rate behind them.
- Match capacity to volumeConfirm the timings hold at your real monthly case count, especially across multiple locations.
Confirmed, consistent timings across the whole chain matter more than the lowest single number on a brochure. Speed you cannot reproduce on a busy week is not a real feature. Practices planning to grow should also read how to scale case volume without turnaround quietly slipping.
How Clear Moves Approaches Turnaround
Our approach begins by making the parts you control easy to get right. Clear submission requirements and a defined records standard keep cases from bouncing before design starts, and our scan-to-aligner planning workflow maps how a case moves through assessment, setup, approval and production. A structured setup keeps the review decisive, and the doctor portal shows live case status so you are never guessing where a case sits.
On our side, planning, manufacturing and quality control are run as one pipeline rather than separate desks, so a case does not wait in the gaps between stages. Because we plan for predictability — the same discipline behind outsourced treatment planning and digital production workflows — fewer cases return as refinements, which is the turnaround number that actually reaches your patient.
Before you commit to any manufacturing partner, ask them to define the clock and give you all three timings to your market. Fast should mean a predictable, well-planned case in your patient’s hands — not a quick figure that hides a slow chain.
Get Your True Turnaround, End to End
Tell us your market and case mix. We’ll give you design, production and transit times to your door — and show you where to shave days you didn’t know you were losing.
[email protected]Frequently Asked Questions
What does “turnaround time” mean in clear aligner manufacturing?
Why is quoted production time shorter than what my practice actually experiences?
What causes most aligner turnaround delays?
Does faster manufacturing mean faster treatment for the patient?
How does international shipping affect turnaround?
How can my practice reduce turnaround without changing suppliers?
How should I compare turnaround between two manufacturers?
Worldwide
